Rv1985c, a promising novel antigen for diagnosis of tuberculosis infection from BCG-vaccinated controls

BMC Infectious Diseases

Volumn 10, Issue , 2010, Pages

  Chen, Jiazhen ^a,b,c   Wang, Sen ^a   Zhang, Ying ^c   Su, Xiaodi ^b   Wu, Jing ^b   Shao, Lingyun ^a   Wang, Feifei ^b   Zhang, Shu ^a   Weng, Xinhua ^a   Wang, Honghai ^b   Zhang, Wenhong ^a,b  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CULTURE FILTRATE PROTEIN 10; EARLY SECRETORY ANTIGENIC TARGET 6; GAMMA INTERFERON; MYCOBACTERIUM ANTIGEN; RV1985C ANTIGEN; UNCLASSIFIED DRUG; BACTERIAL ANTIGEN; BACTERIUM ANTIBODY; DIAGNOSTIC AGENT; IMMUNOGLOBULIN G; RECOMBINANT PROTEIN;

ADOLESCENT; ADULT; AGED; ANTIGEN RECOGNITION; ARTICLE; BCG VACCINATION; CELLULAR IMMUNITY; CHILD; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HUMAN; HUMORAL IMMUNITY; INTERMETHOD COMPARISON; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; SCHOOL CHILD; SENSITIVITY ANALYSIS; SERODIAGNOSIS; BLOOD; COMPARATIVE STUDY; EVALUATION; IMMUNOASSAY; IMMUNOLOGY; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; SECRETION; SENSITIVITY AND SPECIFICITY; T LYMPHOCYTE; TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIOLOGICAL TECHNIQUES; BCG VACCINE; CHILD; FEMALE; HUMANS; IMMUNOASSAY; IMMUNOGLOBULIN G; INTERFERON-GAMMA; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; RECOMBINANT PROTEINS; SENSITIVITY AND SPECIFICITY; T-LYMPHOCYTES; TUBERCULOSIS; YOUNG ADULT;

EID: 77957348867     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-10-273     Document Type: Article

References (38)

1. WHO Global tuberculosis control-surveillance, Planning, Financing. WHO report 2008 2008, WHO.
2. Sterling TR. New approaches to the treatment of latent tuberculosis. Semin Respir Crit Care Med 2008, 29(5):532-541. 10.1055/s-0028-1085704, 18810686.
3. Fine PE, Bruce J, Ponnighaus JM, Nkhosa P, Harawa A, Vynnycky E. Tuberculin sensitivity: conversions and reversions in a rural African population. Int J Tuberc Lung Dis 1999, 3(11):962-975.
4. Ewer K, Deeks J, Alvarez L, Bryant G, Waller S, Andersen P, Monk P, Lalvani A. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 2003, 361(9364):1168-1173. 10.1016/S0140-6736(03)12950-9, 12686038.
5. Al-Attiyah R, Mustafa AS. Characterization of human cellular immune responses to novel Mycobacterium tuberculosis antigens encoded by genomic regions absent in Mycobacterium bovis BCG. Infection and Immunity 2008, 76(9):4190-4198. 10.1128/IAI.00199-08, 2519442, 18573897.
6. Andersen P, Munk ME, Pollock JM, Doherty TM. Specific immune-based diagnosis of tuberculosis. Lancet 2000, 356(9235):1099-1104. 10.1016/S0140-6736(00)02742-2, 11009160.
7. Mustafa AS. Recombinant and synthetic peptides to identify Mycobacterium tuberculosis antigens and epitopes of diagnostic and vaccine relevance. Tuberculosis (Edinb) 2005, 85(5-6):367-376. 10.1016/j.tube.2005.08.006, 16253561.
8. Mukherjee P, Dutta M, Datta P, Dasgupta A, Pradhan R, Pradhan M, Kundu M, Basu J, Chakrabarti P. The RD1-encoded antigen Rv3872 of Mycobacterium tuberculosis as a potential candidate for serodiagnosis of tuberculosis. Clinical Microbiology and Infection 2007, 13(2):146-152. 10.1111/j.1469-0691.2006.01660.x, 17328726.
9. Rosenkrands I, Aagaard C, Weldingh K, Brock I, Dziegiel MH, Singh M, Hoff S, Ravn P, Andersen P. Identification of Rv0222 from RD4 as a novel serodiagnostic target for tuberculosis. Tuberculosis (Edinb) 2008, 88(4):335-343. 10.1016/j.tube.2007.12.001, 18243798.
10. Okkels LM, Brock I, Follmann F, Agger EM, Arend SM, Ottenhoff TH, Oftung F, Rosenkrands I, Andersen P. PPE protein (Rv3873) from DNA segment RD1 of Mycobacterium tuberculosis: strong recognition of both specific T-cell epitopes and epitopes conserved within the PPE family. Infection and Immunity 2003, 71(11):6116-6123. 10.1128/IAI.71.11.6116-6123.2003, 219556, 14573626.
11. Behr MA, Wilson MA, Gill WP, Salamon H, Schoolnik GK, Rane S, Small PM. Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science 1999, 284(5419):1520-1523. 10.1126/science.284.5419.1520, 10348738.
12. Roche PW, Feng CG, Britton WJ. Human T-cell epitopes on the Mycobacterium tuberculosis secreted protein MPT64. Scandinavian Journal of Immunology 1996, 43(6):662-670. 10.1046/j.1365-3083.1996.d01-260.x, 8658056.
13. Tavares RC, Salgado J, Moreira VB, Ferreira MA, Mello FC, Leung JW, Fonseca Lde S, Spallek R, Singh M, Saad MH. Interferon gamma response to combinations 38 kDa/CFP-10, 38 kDa/MPT-64, ESAT-6/MPT-64 and ESAT-6/CFP-10, each related to a single recombinant protein of Mycobacterium tuberculosis in individuals from tuberculosis endemic areas. Microbiology and Immunology 2007, 51(3):289-296.
14. Qie YQ, Wang JL, Zhu BD, Xu Y, Wang QZ, Chen JZ, Wang HH. Evaluation of a new recombinant BCG which contains mycobacterial antigen ag85B-mpt64(190-198)-mtb8.4 in C57/BL6 mice. Scandinavian Journal of Immunology 2008, 67(2):133-139. 10.1111/j.1365-3083.2007.02048.x, 18201368.
15. Kalra M, Grover A, Mehta N, Singh J, Kaur J, Sable SB, Behera D, Sharma P, Verma I, Khuller GK. Supplementation with RD antigens enhances the protective efficacy of BCG in tuberculous mice. Clinical Immunology 2007, 125(2):173-183. 10.1016/j.clim.2007.07.007, 17766185.
16. Liu XQ, Dosanjh D, Varia H, Ewer K, Cockle P, Pasvol G, Lalvani A. Evaluation of T-cell responses to novel RD1-and RD2-encoded Mycobacterium tuberculosis gene products for specific detection of human tuberculosis infection. Infect Immun 2004, 72(5):2574-2581. 10.1128/IAI.72.5.2574-2581.2004, 387854, 15102765.
17. Chen J, Su X, Zhang Y, Wang S, Shao L, Wu J, Wang F, Zhang S, Wang J, Weng X, et al. Novel recombinant RD2-and RD11-encoded Mycobacterium tuberculosis antigens are potential candidates for diagnosis of tuberculosis infections in BCG-vaccinated individuals. Microbes Infect 2009, 11(10-11):876-885. 10.1016/j.micinf.2009.05.008, 19467342.
18. Blokpoel MC, O'Toole R, Smeulders MJ, Williams HD. Development and application of unstable GFP variants to kinetic studies of mycobacterial gene expression. Journal of Microbiological Methods 2003, 54(2):203-211. 10.1016/S0167-7012(03)00044-7, 12782376.
19. Carrara S, Vincenti D, Petrosillo N, Amicosante M, Girardi E, Goletti D. Use of a T cell-based assay for monitoring efficacy of antituberculosis therapy. Clinical Infectious Diseases 2004, 38(5):754-756. 10.1086/381754, 14986262.
20. Dheda K, Pooran A, Pai M, Miller RF, Lesley K, Booth HL, Scott GM, Akbar AN, Zumla A, Rook GA. Interpretation of Mycobacterium tuberculosis antigen-specific IFN-gamma release assays (T-SPOT.TB) and factors that may modulate test results. Journal of Infection 2007, 55(2):169-173. 10.1016/j.jinf.2007.02.005, 17448540.
21. Hirsch CS, Toossi Z, Othieno C, Johnson JL, Schwander SK, Robertson S, Wallis RS, Edmonds K, Okwera A, Mugerwa R, et al. Depressed T-cell interferon-gamma responses in pulmonary tuberculosis: analysis of underlying mechanisms and modulation with therapy. Journal of Infectious Diseases 1999, 180(6):2069-2073. 10.1086/315114, 10558973.
22. Zhang H, Wang J, Lei J, Zhang M, Yang Y, Chen Y, Wang H. PPE protein (Rv3425) from DNA segment RD11 of Mycobacterium tuberculosis: a potential B-cell antigen used for serological diagnosis to distinguish vaccinated controls from tuberculosis patients. Clin Microbiol Infect 2007, 13(2):139-145. 10.1111/j.1469-0691.2006.01561.x, 17328725.
23. Shao L, Zhang W, Zhang S, Chen CY, Jiang W, Xu Y, Meng C, Weng X, Chen ZW. Potent immune responses of Ag-specific Vgamma2Vdelta2 + T cells and CD8 + T cells associated with latent stage of Mycobacterium tuberculosis coinfection in HIV-1-infected humans. AIDS 2008, 22(17):2241-2250. 10.1097/QAD.0b013e3283117f18, 2743094, 18981763.
24. Zhang H, Wang J, Lei J, Zhang M, Yang Y, Chen Y, Wang H. PPE protein (Rv3425) from DNA segment RD11 of Mycobacterium tuberculosis: a potential B-cell antigen used for serological diagnosis to distinguish vaccinated controls from tuberculosis patients. Clinical Microbiology and Infection 2007, 13(2):139-145. 10.1111/j.1469-0691.2006.01561.x, 17328725.
25. Pottumarthy S, Wells VC, Morris AJ. A comparison of seven tests for serological diagnosis of tuberculosis. Journal of Clinical Microbiology 2000, 38(6):2227-2231. 86769, 10834981.
26. Imaz MS, Comini MA, Zerbini E, Sequeira MD, Latini O, Claus JD, Singh M. Evaluation of commercial enzyme-linked immunosorbent assay kits for detection of tuberculosis in Argentinean population. Journal of Clinical Microbiology 2004, 42(2):884-887. 10.1128/JCM.42.2.884-887.2004, 344447, 14766880.
27. Dosanjh DP, Hinks TS, Innes JA, Deeks JJ, Pasvol G, Hackforth S, Varia H, Millington KA, Gunatheesan R, Guyot-Revol V, et al. Improved diagnostic evaluation of suspected tuberculosis. Ann Intern Med 2008, 148(5):325-336. 2761734, 18316751.
28. Brock I, Weldingh K, Leyten EM, Arend SM, Ravn P, Andersen P. Specific T-cell epitopes for immunoassay-based diagnosis of Mycobacterium tuberculosis infection. J Clin Microbiol 2004, 42(6):2379-2387. 10.1128/JCM.42.6.2379-2387.2004, 427833, 15184408.
29. Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 2008, 149(3):177-184.
30. Steingart KR, Henry M, Laal S, Hopewell PC, Ramsay A, Menzies D, Cunningham J, Weldingh K, Pai M. Commercial serological antibody detection tests for the diagnosis of pulmonary tuberculosis: a systematic review. PLoS Med 2007, 4(6):e202. 10.1371/journal.pmed.0040202, 1891320,1891320, 17564490.
31. Julian E, Matas L, Alcaide J, Luquin M. Comparison of antibody responses to a potential combination of specific glycolipids and proteins for test sensitivity improvement in tuberculosis serodiagnosis. Clinical and Diagnostic Laboratory Immunology 2004, 11(1):70-76. 321345, 14715547.
32. Weldingh K, Rosenkrands I, Okkels LM, Doherty TM, Andersen P. Assessing the serodiagnostic potential of 35 Mycobacterium tuberculosis proteins and identification of four novel serological antigens. Journal of Clinical Microbiology 2005, 43(1):57-65. 10.1128/JCM.43.1.57-65.2005, 540170, 15634951.
33. Hoff ST, Abebe M, Ravn P, Range N, Malenganisho W, Rodriques DS, Kallas EG, Soborg C, Mark Doherty T, Andersen P, et al. Evaluation of Mycobacterium tuberculosis--specific antibody responses in populations with different levels of exposure from Tanzania, Ethiopia, Brazil, and Denmark. Clin Infect Dis 2007, 45(5):575-582. 10.1086/520662, 17682991.
34. Kassa-Kelembho E, Kassa E, Zandanga G, Service YB, Ignaleamoko A, Talarmin A. Poor performance of a novel serological test for diagnosis of pulmonary tuberculosis in Bangui, Central African Republic. Clin Vaccine Immunol 2006, 13(6):702-703. 10.1128/CVI.00194-05, 1489549, 16760330.
35. McConkey SJ, Youssef FG, Azem E, Frenck RW, Weil GJ. Evaluation of a rapid-format antibody test and the tuberculin skin test for diagnosis of tuberculosis in two contrasting endemic settings. Int J Tuberc Lung Dis 2002, 6(3):246-252.
36. Lyashchenko K, Colangeli R, Houde M, Al Jahdali H, Menzies D, Gennaro ML. Heterogeneous antibody responses in tuberculosis. Infect Immun 1998, 66(8):3936-3940. 108457, 9673283.
37. Diel R, Loddenkemper R, Meywald-Walter K, Niemann S, Nienhaus A. Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis. Am J Respir Crit Care Med 2008, 177(10):1164-1170. 10.1164/rccm.200711-1613OC, 18276940.
38. Bakir M, Millington KA, Soysal A, Deeks JJ, Efee S, Aslan Y, Dosanjh DP, Lalvani A. Prognostic value of a T-cell-based, interferon-gamma biomarker in children with tuberculosis contact. Ann Intern Med 2008, 149(11):777-787. 2730556, 18936496.